The slow march of clinical biomarkers to become surrogate endpoints
Clinicians have often pushed for certain biomarkers to move from serving a purely informative role in clinical trials to becoming…
20 Apr 2026
Magazine: Digital twins become the new battleground for CDMOs
Contract Development and Manufacturing Organisations’ (CDMOs) expansion into more complex biopharmaceuticals, gene therapy and advanced product sectors is prompting a competitive position shift. This month’s cover feature examines the role…
17 Apr 2026
The innovators working to make in vivo cell therapy a reality
As investors signal early interest in in vivo cell therapies and raise the modality’s potential for commercial success, a growing industry of suppliers is innovating to safeguard their viability. Cell…
31 Mar 2026
Non-invasive diagnostics in endometriosis: at the cusp of a turning point
Endometriosis affects an estimated 10% of reproductive-age women worldwide. Early diagnosis is crucial for preventing disease progression, improving pain management, and preserving fertility, yet long delays are common. In fact,…
31 Mar 2026
Navigating commercial gaps to supercharge the UK life sciences sector
Off the northwestern coast of mainland Europe, there sits an island with big ambitions for its life sciences sector. Though small in comparison to competitors like the US and China,…
27 Mar 2026
Podcast: European biotech rallies against US and China powerhouses
As Lisbon played host to BIO Europe Spring, an annual conference that brings together professionals across the global biotech sector, the continent’s journey back to prime competitiveness took centre stage.…
25 Mar 2026
Researchers become scientific tastemakers by handing more R&D to autonomous labs
Pharmaceutical R&D is falling increasingly to artificial intelligence (AI)-guided autonomous laboratories, and the people behind them say the role of human researchers may soon be transformed but not replaced. Fundamentally,…